In one paragraphArticle in Journal of personalized medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Magdalena PostlDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.
Christoph GrimmDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2948-8129 Melina DanischDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0009-0003-0289-3738 Patrik PetrovDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.
Mara MantovanDepartment of Obstetrics and Gynecology, Medical University Innsbruck, 6020 Innsbruck, Austria.
Alexander ReinthallerDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7205-0985 Stephan PolterauerDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9649-4505 Christian MarthDepartment of Obstetrics and Gynecology, Medical University Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-8965-9981 Nicole ConcinDepartment of Obstetrics and Gynecology, Division of General Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, 1090 Vienna, Austria.
Alain Gustave ZeimetDepartment of Obstetrics and Gynecology, Medical University Innsbruck, 6020 Innsbruck, Austria.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chemoradiotherapyearly-stage cervical cancerlaparoscopylaparotomylymphatic metastasisprogression-free survivalradical hysterectomysurgical staginguterine cervical neoplasms
Identifiers
PMID42783506
PMCPMC13608262
What OpenQuestion holds
Textmetadata
Read underepoch 390